Comparison between Manilam Industries IPO and Rednex Pharmaceuticals IPO.
Manilam Industries IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rednex Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | NEXGEN Financial Solutions Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | MAS Services Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Manilam Industries IPO is up to ₹37.94 Cr whereas the issue size of the Rednex Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Manilam Industries IPO is ₹69.00 per share and of Rednex Pharmaceuticals IPO is .
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | |
| Issue Price (Upper) | ₹69.00 per share | |
| Issue Price (Final) | ₹69.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | |
| Fresh Issue Size | 44,06,000 shares | 27,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹30.40 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 10,92,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹7.53 Cr | up to ₹0.00 Cr |
| Issue Size Total | 54,98,000 shares | 27,36,000 shares |
| Issue Size Total (Amount) | up to ₹37.94 Cr | up to ₹0.00 Cr |
Manilam Industries IPO opens on Feb 20, 2026, while Rednex Pharmaceuticals IPO opens on . The closing date of Manilam Industries IPO and Rednex Pharmaceuticals IPO is Feb 24, 2026, and , respectively.
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Feb 19, 2026 | |
| Issue Open | Feb 20, 2026 | |
| Issue Close | Feb 24, 2026 | |
| Basis Of Allotment (Tentative) | Feb 25, 2026 | |
| Initiation of Refunds (Tentative) | Feb 26, 2026 | |
| Credit of Share (Tentative) | Feb 26, 2026 | |
| Listing date (Tentative) | Feb 27, 2026 | |
| Anchor Lockin End date 1 | Mar 27, 2026 | |
| Anchor Lockin End date 2 | May 26, 2026 |
Manilam Industries IPO P/E ratio is 16.04, as compared to Rednex Pharmaceuticals IPO P/E ratio of .
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 78.79 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 16.04 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹150.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 24.80 | 58.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.68 | 23.29 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.30 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.80 | 45.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Manilam Industries IPO Retail Individual Investors (RII) are offered 19,28,000 shares while in Rednex Pharmaceuticals IPO retail investors are offered 19,28,000 shares. Qualified Institutional Buyers (QIB) are offered 11,04,000 shares in Manilam Industries IPO and 0 shares in Rednex Pharmaceuticals IPO.
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 16,38,000 shares | 0 shares |
| Market Maker Reservation | 2,92,000 shares | 0 shares |
| QIB | 11,04,000 shares | 0 shares |
| NII | 8,28,000 shares | 0 shares |
| RII | 19,28,000 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 54,98,000 shares | 0 shares |
Manilam Industries IPO subscribed 4.39x in total, whereas Rednex Pharmaceuticals IPO subscribed .
| Manilam Industries IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 2.24x | |
| NII (times) | 12.49x | |
| Big NII (times) | 14.16x | |
| Small NII (times) | 9.14x | |
| RII (times) | 5.88x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.39x |
